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Trends in management of abdominal aortic
aneurysms
Sami A. Chadi, MD, MSc, Bradley W. Rowe, MD, Kelly N. Vogt, MD, MSc, Teresa V. Novick, RN,
Jeremy R. Harris, MD, Guy DeRose, MD, and Thomas L. Forbes, MD, London, Ontario, Canada
Objective: The purpose of this study was to evaluate patients undergoing elective repair of infrarenal abdominal aortic
aneurysms (AAAs) and the longitudinal trends in surgical management (open repair vs endovascular aneurysm repair
[EVAR]), factors associated with the choice of surgical technique, and differences in the rate of in-hospital mortality at
a single large-volume Canadian center.
Methods: This retrospective cohort study used data from a prospectively collected vascular surgery database and reviewed
all patients undergoing elective repair of an infrarenal AAA over a recent 10-year period (June 2000-May 2010).
Information was reviewed regarding surgical techniques, patient demographics, and short-term outcomes. Subsequent
analysis included univariate statistics and multivariable logistic regression with data presented as odds ratios (ORs) and
95% confidence intervals (CIs).
Results: A total of 1942 patients underwent elective AAA repair over this 10-year study period, 1067 (54.9%) via open
repair and 875 (45.1%) via EVAR. The proportion of patients undergoing EVARwas significantly higher in the latter half
of the study period compared to the first half (55.8% vs 33.9%; P< .01). Older patients (75 vs 71; P< .01) and those with
higher American Society of Anesthesiologists classifications (P< .01) were more likely to receive endovascular repair than
open repair. The overall in-hospital mortality rate in the entire cohort was low (2.3% for EVAR and 3.9% for open repair),
and after multivariable logistic regression and adjustment for preoperative factors, in-hospital mortality was significantly
higher in patients with open AAA repair (OR, 1.8; 95% CI, 1.04-3.13; P  .04).
Conclusions: This 10-year analysis shows a significant shift toward an endovascular approach in the repair of infrarenal
AAAs at our Canadian center. Similar to other jurisdictions, higher risk and older patients are more likely to be treated
with an endovascular repair resulting in a survival advantage in these patients compared to standard open repair. ( J Vasc
Surg 2012;55:924-8.)
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tBeginning with its initial description in 1991,1 endo-
vascular aneurysm repair (EVAR) has become the preferred
method of elective management of abdominal aortic aneu-
rysms (AAAs) in many jurisdictions. Short-term advantages
of this less invasive technique are now widely accepted with
several randomized trials consistently showing that in
acceptable-risk patients, endovascular repair results in a
lower perioperative mortality risk, shorter hospitalization,
and a lower rate of major postoperative morbidities.2,3
Over the last decade, EVAR has been enthusiastically ad-
opted as the preferred method of repair in many institu-
tions,4 with some centers in the United States using endo-
vascular repair in over 80% of elective cases.5
It is apparent that different healthcare delivery systems are
able to adopt new and more expensive technologies at differ-
ent rates and to different extents. For example, until well into
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924he most recent decade (2003-2004), EVAR continued to
ccount for 10% of elective repairs in Canadian patients, a
tilization rate well below that seen south of the border.6
nitially, the additional cost attributed to the endografts did
ot allow for widespread dissemination in a system where
ospitals had predetermined global operating budgets. In our
rovince of Ontario, it was not until a health technology
ssessment led to dedicated EVAR funding, after determining
ost equivalence in high-risk patients, did more widespread
issemination of this technology occur.7
Additionally, as opposed to many areas in the United
tates, vascular surgery services in Canada, specifically an-
urysm surgery, are increasingly centralized at fewer, but
igher-volume centers.8 Our university-affiliated institu-
ion provides vascular surgery care to approximately 1.9
illion people and is the only center in southwestern
ntario to offer endovascular repair of aortic aneurysms.
ndovascular repair has increasingly become our preferred
ethod of aneurysm management in appropriate patients,
specially in our more elderly patients with medical comor-
idities. The purpose of the present study was to evaluate
hese trends in the management of AAAs over the course of
he past decade and to assess the effects of preoperative
actors on in-hospital mortality.
ETHODS
A retrospective review was performed on our prospec-
ively maintained database to identify patients who under-
ent elective endovascular or conventional open repair of
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Volume 55, Number 4 Chadi et al 925an infrarenal AAA between June 1, 2000 andMay 30, 2010
at our university-affiliated medical center. The time interval
was chosen to provide an overview of shifts in the manage-
ment of AAA disease over the course of the past decade
during which more stable funding for EVAR was obtained.
Patients excluded from this analysis were those with
pararenal and suprarenal aortic aneurysms, visceral arterial
aneurysms, or isolated iliac aneurysms. Furthermore, pa-
tients with infected and ruptured aneurysms were also
excluded from this study. Demographic information was
collected, including patient age, gender, and American
Society of Anesthesiologists (ASA) classification as a mea-
sure of preoperative health status and perioperative risk.
Postoperative information was obtained, including inten-
sive care unit (ICU) admission, length of hospital stay, the
need for conversion to open repair, as well as in-hospital
mortality and cause of death. For endovascular procedures,
the type of endograft and its manufacturer were also noted.
The primary outcome measure assessed was in-hospital
mortality in each of the EVAR and open repair groups.
Secondary outcomes included ICU admission and length
of hospital stay.
The decisions regarding type of repair and device selec-
tion and sizing in EVAR cases were made at the discretion
of the primary operating surgeon. Appropriateness for en-
dovascular repair was decided on based on anatomic fea-
tures and patient medical comorbidities. Endovascular
cases were performed with one of the following endografts:
Talent (Medtronic, Santa Rosa, Calif), Zenith (Cook,
Bloomington, Ind), Endurant (Medtronic), and Anaconda
(Vascutek Terumo, Renfrewshire, Scotland). All EVAR
procedures were performed in the operating room with
portable C-arm fluoroscopy. Open AAA repairs were per-
formed via a transperitoneal route. Outcome measures in
this study were restricted to those during the index hospi-
talization.
Descriptive univariate statistical analyses were per-
formed with data reported as mean  SD unless otherwise
indicated. Comparisons between continuous variables were
performed used a two-tailed t test with categorical variable
comparisons performed with 2 analyses. Differences in
length of hospital stay were assessed using nonparametric
Mann-Whitney U testing. Finally, multivariable logistic
regression was performed while adjusting for various pre-
operative variables. Results are reported as odds ratios
(ORs) with 95% confidence intervals (CIs). A P .05 level
of statistical significance was used.
This study received approval from the University of
Western Ontario Research Ethics Board for Health Sci-
ences Research Involving Human Subjects.
RESULTS
Over this 10-year period (2000 to 2010), a total of
1942 patients underwent elective repairs of their AAAs at
our institution. Themean age of these patients was 73 years
(SD, 8.2 years), while 299 patients (15.4%) were women
and 1912 (98.5%) had an ASA classification of III or IV. A
total of 875 EVARs and 1067 open AAA repairs were ierformed over this time period. The combined early and
ate conversion rate of EVAR to open repair was 1.42% over
his time period.
The information comparing demographics and preop-
rative patient characteristics between the treatment groups
s summarized in Table I. Patients managed by EVAR were
lder than the open repair group (75 vs 71 years; P  .01)
nd more likely to be men (88% vs 82%; P  .01). Patients
ith a higher ASA classification were more likely to be
anaged using EVAR. On univariate analysis, patients who
nderwent open repair had a higher in-hospital mortality
ate than those who underwent endovascular repair (3.9%
s 2.3%; P  .04). Similarly, patients who underwent
VAR were significantly less likely to require an ICU
dmission (3.6% vs 8.7%; P  .01). In the latter half of our
tudy, more patients were managed by EVAR compared to
he first 5 years of the reported decade (55.8% vs 33.9%;
 .01). This transition coincided with the achievement of
ore stable funding for EVAR procedures in higher-risk
ndividuals.
Multivariable logistic regression was performed to de-
ermine factors associated with management by EVAR vs
pen repair. After adjustment for preoperative variables and
ime, patients receiving EVAR tended to be older andmore
ikely to be men (Table II). Patients receiving EVAR were
ore likely to be in ASA class IV as compared to their
ounterparts receiving open repairs. AAA repairs performed
able I. Demographics and preoperative characteristics
f patients receiving open and EVAR repairs of AAAs
Open
(n  1067)
EVAR
(n  875)
Univariate
P value
ge in years,
mean (SD) 71 (8.05) 75 (8.04) .01
emale, n (%) 189 (17.8) 109 (12.5) .01
SA score, n (%) .01a
I 0 (0) 0 (0)
II 4 (0.4) 8 (0.9)
III 1028 (97.2) 227 (26.2)
IV 25 (2.4) 633 (72.9)
ength of
hospital stay
in days,
median
(IQR) 7 (6-9) 4 (3-5) .01
eed for ICU, n
(%) 90 (8.7) 31 (3.6) .01
n-hospital
mortality 42 (3.9) 20 (2.3) .04
iming of repair,
n (%) .01
2000-2005 495 (66.1) 297 (33.9)
2006-2010 472 (44.2) 578 (55.8)
AAs, Abdominal aortic aneurysms; ASA, American Society of Anesthesi-
logists; EVAR, endovascular aneurysm repair; ICU, intensive care unit;
QR, interquartile range.
Patients with ASA I and II excluded (too few patients), P value represents
he difference between the proportion of patients in ASA class III and IV,
VAR vs open repair.n the latter half of this time interval were significantly more
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April 2012926 Chadi et allikely to be performed with an endovascular stent graft. The
10-year trend in the use of EVAR is presented in Fig 1. In
the earlier years of this decade, EVAR represented only 30%
of all cases, but by 2010 had increased to 66% of cases in
that calendar year. Fig 2 further demonstrates the trend
toward increased use of EVAR in more medically compro-
mised patients as there is a progressive increase in the
number of patients classified as ASA IV receiving EVAR
Table II. Results of multivariable logistic regression
comparing open AAA repair to EVAR
P value OR (95% CI)
Older age .01 0.95 (0.95-0.96)
Female gender .01 1.6 (1.2-2.3)
Higher ASA score .01 0.03 (0.02-0.04)
AAA repair in 2006-2010 .01 0.66 (0.52-0.84)
AAA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiol-
ogists; CI, confidence interval; EVAR, endovascular aneurysm repair; OR,
odds ratio.
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Fig 1. Percentage of total procedures performed annually via
endovascular aneurysm repair (EVAR) or open techniques over the
2000 to 2010 time period.
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Fig 2. Percentage of patients classified as American Society of
Anesthesiologists IV (ASA IV) receiving endovascular aneurysm
repair (EVAR) over the 2000 to 2010 time period. The trend line
represents the averages between each individual time period.over this 10-year period. uAs previously mentioned, patients undergoing open
epair had higher in-hospital mortality compared with
hose undergoing EVAR. Table III demonstrates the re-
ults of multivariable logistic regression for mortality. Even
fter adjusting for age and ASA classification, open repair
as associated with a higher risk of mortality (OR, 1.8).
ause of death in this series was most commonly related
irectly to cardiopulmonary comorbidities (78%).
The changes in specific endograft utilization were ob-
erved as several new endografts became available during
his time period. In the early part of the decade, the most
ommon endografts used were Talent and Zenith reflecting
ur preference for transrenally fixated endografts,9 whereas
n the latter part of the decade, other transrenally fixated
ndografts with active fixation, including Endurant and
enith, have been used in the majority of cases. This
nformation is summarized in Fig 3.
ISCUSSION
In this study, we have described our experience over the
ast decade in managing AAAs with the increasingly fre-
uent utilization of endovascular technology. It was not
ong ago that10% of elective AAA repairs in Canada were
erformed with endovascular stent grafts, with the majority
aking place at large university-affiliated medical centers
uch as ours.6 Our experience is similar to other Canadian
enters as further adoption of EVAR was initially limited by
he lack of dedicated financial resources. It was not until
pproximately 5 years ago that a more stable funding base
ermitted more widespread adoption.7 According to ad-
inistrative databases, approximately 40% of nonurgent
neurysms are currently being treated with endovascular
tent grafts in Ontario.
Our results demonstrate the expected increased utiliza-
ion of endovascular repairs for elective AAAs during this
0-year period with a continued overall low perioperative
ortality despite a high proportion of higher-risk individ-
als (ASA III or IV). Over the last 3 years, this EVAR rate
eems to have reached an “equilibrium” in which approxi-
ately two-thirds of patients undergo EVAR. This rate of
tilization is similar to that of many centers worldwide,4
ut it continues to seem somewhat conservative when
ompared to some centers in the United States.5 In con-
rast to our steadily increased EVAR utilization rate, the
xperience in some US centers has been more of an irreg-
able III. Results of multivariable logistic regression for
ortality comparing open AAA repair to EVAR
P value OR (95% CI)
pen repair .04 1.8 (1.04-3.13)
igher ASA score .63 1.05 (0.87-1.26)
ge .94 1.00 (0.97-1.03)
AA, Abdominal aortic aneurysm; ASA, American Society of Anesthesiol-
gists; CI, confidence interval; EVAR, endovascular aneurysm repair; OR,
dds ratio.lar growth. For example, the Oschner Clinic reported a
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Volume 55, Number 4 Chadi et al 92770% utilization rate in the 1990s followed by a decrease to
40% in the early 2000s. This increased to over 80% by
2008.5
We continue to prefer EVAR in higher-risk individuals
with suitable anatomy where there is no doubt that this less
invasive technique offers a survival advantage, at least in the
short term.10 Endovascular repair in lower-risk patients, or
those with a longer life expectancy, is reserved for those
patients with more optimal anatomy that permits one to
expect a more durable repair.
Open repair was still performed in one-third of our
patients during the latter 3 years of this review. It is impor-
tant to note the relatively low perioperative mortality rate
(3.9%) with open repair in the ASA class III and IV patients
in this group. Although not the main subject of this review,
many of these patients would have preferentially received
an endovascular repair given their risk stratification, but
their anatomy precluded a successful or durable endovas-
cular repair. Open repair still offered these patients a rela-
tively low mortality rate and our experience offers evidence
to support the continued use of open repair in appropriately
selected patients.
The primary outcome variable in this study was in-
20
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Fig 3. Endovascular aneurysm repair (EVAR) device-specific us-
age in 2000 to 2002 and 2008 to 2010.hospital mortality, which revealed a significantly higher Sortality in patients receiving an open elective infrarenal
AA repair compared to EVAR. This is associated with
ignificantly fewer ICU admissions in the EVAR group as
ell. These early survival benefits echo those reported by
andomized controlled trials such as the Dutch Random-
zed Endovascular Aneurysm Management (DREAM)
rial3 and the Comparison of Endovascular Aneurysm Re-
air with open Repair in Patients with Abdominal Aortic
neurysm (EVAR-1).2 These studies limit their patient
opulations to relatively healthier patients who were deter-
ined to be suitable for EVAR or open repair by their
hysician.3,11 Our patients represented a more disparate
roup with many more high-risk individuals who would
ave not have met the inclusion criteria of these random-
zed trials.10
In addition to more advanced age, male gender was
etermined to be a significant predictor of EVAR use. This
ale predilection for EVAR has been observed previously
nd attributed to the suboptimal anatomy that women
ore frequently exhibit that precludes successful endovas-
ular repair.12,13 For example, inadequate femoral and iliac
ccess vessels have been observed in up to 55% of female
atients and is the most common anatomic reason for
omen to be underrepresented in many EVAR series.11 It
s expected that newer stent grafts with smaller and more
exible delivery systems will decrease this number of ana-
omically unsuitable women.
The results of the present study are limited to those
uring the initial hospitalization and do not include infor-
ation on longer-term patient follow-up, endoleaks, or
einterventions. This is an obvious limitation of the present
tudy as is the retrospective nature of this database review.
owever, the primary goal of this review was to observe the
rends in EVAR utilization during a time period where our
unding base improved and to observe the initial outcomes
ssociated with the choice of method of repair.
In summary, different healthcare systems are able to
dopt newer technology at different rates and to different
xtents. Our experience over the last 10 years reflect those
f a Canadian academic health sciences center where EVAR
as accounted for an increasing proportion of elective AAA
epairs as a more stable funding base was achieved. Up to
wo-thirds of elective cases are currently treated with en-
ografts and this rate of utilization, along with open repair
n appropriately selected patients, has resulted in a contin-
ed low perioperative mortality rate despite increasing pro-
ortions of higher-risk individuals.
UTHOR CONTRIBUTIONS
onception and design: SC, TF
nalysis and interpretation: SC, KV, JH, GD, TF
ata collection: SC, BR, TN
riting the article: SC, KV, TF
ritical revision of the article: SC, BR, KV, TN, JH, GD,
TF
inal approval of the article: SC, BR, KV, TN, JH, GD, TF
tatistical analysis: SC, KV
11
1
1
JOURNAL OF VASCULAR SURGERY
April 2012928 Chadi et alObtained funding: Not applicable
Overall responsibility: TF
REFERENCES
1. Parodi JC, Palmaz JC, Barone HD. Transfemoral intraluminal graft
implantation for abdominal aortic aneurysms. Ann Vasc Surg 1991;5:
491-9.
2. Greenhalgh RM, Brown LC, Kwong GP, Powell JT, Thompson SG;
EVAR trial participants. Comparison of endovascular aneurysm repair
with open repair in patients with abdominal aortic aneurysm (EVAR
trial 1), 30-day operative mortality results: randomised controlled trial.
Lancet 2004;364:843-8.
3. Prinssen M, Verhoeven EL, Buth J, Cuypers PW, van Sambeek MR,
Balm R, et al. A randomized trial comparing conventional and endovas-
cular repair of abdominal aortic aneurysms. N Engl J Med 2004;351:
1607-18.
4. Cao P, Verzini F, Parlani G, Romano L, De Rango P, Pagliuca V, et al.
Clinical effect of abdominal aortic aneurysm endografting: 7-year con-
current comparison with open repair. J Vasc Surg 2004;40:841-8.
5. Albuquerque FC Jr, Tonnessen BH, Noll RE Jr, Cires G, Kim JK,
Sternbergh WC 3rd. Paradigm shifts in the treatment of abdominal
aortic aneurysm: trends in 721 patients between 1996 and 2008. J Vasc
Surg 2010;51:1348-52; discussion 1352-3.
6. Forbes TL, Lawlor DK, Derose G, Harris KA. National audit of the
recent utilization of endovascular abdominal aortic aneurysm repair in
Canada: 2003 to 2004. J Vasc Surg 2005;42:410-4. S7. Tarride JE, Blackhouse G, De Rose G, Novick T, Bowen JM, Hopkins
R, et al. Cost-effectiveness analysis of elective endovascular repair com-
pared with open surgical repair of abdominal aortic aneurysms for
patients at a high surgical risk: a 1-year patient-level analysis conducted
in Ontario, Canada. J Vasc Surg 2008;48:779-87.
8. Forbes TL, Lawlor DK, Derose G, Harris KA. Examination of the trend
in Canada toward geographic centralization of aneurysm surgery during
the endovascular era. Ann Vasc Surg 2006;20:63-8.
9. Forbes TL, Harding GE, Lawlor DK, Derose G, Harris KA. Compari-
son of renal function after endovascular aneurysm repair with different
transrenally fixated endografts. J Vasc Surg 2006;44:938-42.
0. Nagpal AD, Forbes TL, Novick TV, Lovell MB, Kribs SW, Lawlor DK,
et al. Midterm results of endovascular infrarenal abdominal aortic
aneurysm repair in high-risk patients. Vasc Endovascular Surg 2007;41:
301-9.
1. Sweet MP, Fillinger MF, Morrison TM, Abel D. The influence of
gender and aortic aneurysm size on eligibility for endovascular abdom-
inal aortic aneurysm repair. J Vasc Surg 2011;54:931-7.
2. Sampaio SM, Panneton JM,Mozes GI, Andrews JC, Noel AA, KarlaM,
et al. Endovascular abdominal aortic aneurysm repair: does gender
matter? Ann Vasc Surg 2004;18:653-60.
3. Velazquez OC, Larson RA, Baum RA, Carpenter JP, Golden MA,
Mitchell ME, et al. Gender-related differences in infrarenal aortic aneu-
rysm morphologic features: issues relevant to Ancure and Talent en-
dografts. J Vasc Surg 2001;33(2 Suppl):S77-84.ubmitted Sep 15, 2011; accepted Oct 18, 2011.
